Form Type: 4

SEC EDGAR Link
Accession Number:0001415889-19-001558
Date:2019-12-19
Issuer: AMPIO PHARMACEUTICALS, INC. (AMPE)
Original Submission Date:

Reporting Person:

GILES RICHARD B
C/O AMPIO PHARMACEUTICALS, INC.
373 INVERNESS PARKWAY, SUITE 200 ENGLEWOOD, CO 80112

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
OPTION (RIGHT TO BUY) 0.465 2019-12-19 deemed execution date A 36,000 (a) 2020-01-14 2029-12-19 common stock 36,000 $0.47 36,000 direct
Footnotes
IDfootnote
f1 3,000 of the options awarded vest and become exercisable on january 14, 2020. on the 14th of each month thereafter, 3,000 of the options awarded vest until fully vested.
WhaleWisdom Logo

Elevate your investments